WellTheory: $14 Million Series A Closed For Expanding AI-Based Autoimmune Care Platform
By Amit Chowdhry ● Oct 15, 2025
WellTheory, a digital health company pioneering whole-person care for autoimmune disease, announced it has raised $14 million in Series A funding led by General Catalyst, with participation from 7wire Ventures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer, and Up2 Opportunity Fund. The new funding round brings WellTheory’s total funding to $26.2 million, and it will accelerate the company’s commercial expansion, partnerships with employers and payors, and development of AI-driven personalization tools for autoimmune care.